Global Pharma
- All
- News
- Videos
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
India, Brazil Can Turn US Tariffs Into Opportunities For Deeper Cooperation: Brazilian Envoy
In an exclusive interview with IANS, Brazil's Ambassador to India, Kenneth Felix Haczynski Da Nobrega, emphasised that India and Brazil are working to turn current global economic challenges, into new opportunities for deeper bilateral cooperation.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
US Opens Door To Tariffs On Pharma, Semiconductors
The United States opened the door Monday to tariffs targeting high-end technology and pharmaceuticals, feeding the uncertainty gripping the global economy in a trade war that Chinese leader Xi Jinping warned can have "no winner."
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Sensex Opens Lower But Holds Above 74,000-Mark Day After Rally
The Indian benchmark indices opened marginally low on Friday amid weak global cues, as selling was seen in the IT, PSU Bank and pharma sectors in the early trade.
-
OTT Releases This Week: 36 Days, Pill, Wild Wild Punjab and More
Junaid Khan’s Maharaj and Rajkummar Rao’s Srikanth are among the top 10 [Non-English] films trending on Netflix this week, globally
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
"Of Standard Quality": Government Sources On Eye Drop Flagged By US Body
The samples of eye drops made by Chennai-based Global Pharma Healthcare - linked to three deaths and blindness in the US, are of "standard quality", sources in the Health Ministry told NDTV today.
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
India, Brazil Can Turn US Tariffs Into Opportunities For Deeper Cooperation: Brazilian Envoy
In an exclusive interview with IANS, Brazil's Ambassador to India, Kenneth Felix Haczynski Da Nobrega, emphasised that India and Brazil are working to turn current global economic challenges, into new opportunities for deeper bilateral cooperation.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
US Opens Door To Tariffs On Pharma, Semiconductors
The United States opened the door Monday to tariffs targeting high-end technology and pharmaceuticals, feeding the uncertainty gripping the global economy in a trade war that Chinese leader Xi Jinping warned can have "no winner."
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Sensex Opens Lower But Holds Above 74,000-Mark Day After Rally
The Indian benchmark indices opened marginally low on Friday amid weak global cues, as selling was seen in the IT, PSU Bank and pharma sectors in the early trade.
-
OTT Releases This Week: 36 Days, Pill, Wild Wild Punjab and More
Junaid Khan’s Maharaj and Rajkummar Rao’s Srikanth are among the top 10 [Non-English] films trending on Netflix this week, globally
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
"Of Standard Quality": Government Sources On Eye Drop Flagged By US Body
The samples of eye drops made by Chennai-based Global Pharma Healthcare - linked to three deaths and blindness in the US, are of "standard quality", sources in the Health Ministry told NDTV today.
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
